SCHEMBL6507167

SCHEMBL6507167

CN1[C@@H]2CC[C@H]1CC(OC(=O)c1ccccc1Cl)C2

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 5/20 0.66
HTR3B O95264 5/20 0.66
HTR3A P46098 5/20 0.66
HTR3D Q70Z44 5/20 0.66
HTR3C Q8WXA8 5/20 0.66
CHRNA7 P36544 2/20 0.66
CYP2D6 P10635 3/20 0.62
LMNA P02545 2/20 0.62
MTOR P42345 2/20 0.62
CHRNA1 P02708 1/20 0.62
CHRNG P07510 1/20 0.62
CYP3A4 P08684 1/20 0.62
HTR1A P08908 1/20 0.62
CHRM5 P08912 1/20 0.62
MAPT P10636 1/20 0.62
CHRM1 P11229 1/20 0.62
CHRNB1 P11230 1/20 0.62
CHRNB2 P17787 1/20 0.62
ADRA2B P18089 1/20 0.62
ADRA2C P18825 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6507170 1.00 HTR3E (0.66) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL7652475 0.90 HTR3A (0.75) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL7652481 0.90 HTR3A (0.75) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL5787520 0.89 HTR3E (0.59) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL5789139 0.84 HTR3A (0.68) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL5789144 0.84 HTR3A (0.68) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL7654510 0.84 CYP2D6 (0.68) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL7654509 0.84 CYP2D6 (0.68) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL10635123 0.84 CYP2D6 (0.66) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL5789103 0.83 HTR3A (0.66) HTR3EHTR3BHTR3AHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054680-A1 Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides COMMONWEALTH SCIENTIFIC INDUSTRIAL RESEARCH ORGANISATION (AU) 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054680-A1 Agonists and antagonists of 5h3-like receptors of invertebrates as pesticides HTR3C, HTR3A, HTR3E HTR3E 3/4885HTR3B 4/4885HTR3A 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.